SEC Filings

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.

Filing date Form Description View
8-K

Report of unscheduled material events or corporate event

View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

View HTML EX-101.INS - XBRL INSTANCE DOCUMENT
8-K

Report of unscheduled material events or corporate event

View HTML
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
S-8

Securities offered to employees pursuant to employee benefit plans

View HTML
10-K

Annual report which provides a comprehensive overview of the company for the past year

View HTML EX-101.INS - EX-101.INS
8-K

Report of unscheduled material events or corporate event

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML

Copyright Morningstar